Arcadia Biosciences (RKDA)

Arcadia Biosciences stock price today, ATLAS forecast and fair value

Consumer Defensive · Packaged Foods · NASDAQ

$0.15▼ -6.17%

Prices as of Oct 26, 2026 · USD

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

43%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Arcadia Biosciences in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Arcadia Biosciences

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Arcadia Biosciences a 43% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.

In half of the simulated outcomes the price ends between $0.12 and $0.17; in 9 out of 10, between $0.08 and $0.25. Estimated annual volatility is 129%.

Key numbers

Revenue (12 months): $4.7M
Revenue growth (YoY): -3.7%
Gross margin: 36.2%
Operating margin: -205.7%
Net margin: -48.2%
Return on equity: -430.9%
Free cash flow (12 months): $-0.9M
Beta: 0.53

What this means

ATLAS does not publish a fair value for RKDA right now, but it does show its odds of rising: somewhat worse than a coin flip.

On the business: revenue fell 3.7% year over year; net margin is 48.2%.

Its beta is 0.53: it tends to move less than the market.

About the company

Arcadia Biosciences Inc. is a biotechnology company focused on plant-based products and agricultural innovations. The company develops and markets specialty crop ingredients, including wheat-based food ingredients designed to improve nutrition and functionality for food manufacturers and processors.

Want to see everything about Arcadia Biosciences?

Get started →

Plans from €3.99 a month.

Frequently asked questions

What does Arcadia Biosciences do?

What is the chance RKDA goes up next month?

43%: somewhat worse than a coin flip. In half of the simulated outcomes, RKDA ends the month between $0.12 and $0.17.

How volatile is RKDA?

ATLAS estimates annual volatility at 129%. In a typical month, half of the outcomes end between $0.12 and $0.17.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer